1. Home
  2. XRX vs VNDA Comparison

XRX vs VNDA Comparison

Compare XRX & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xerox Holdings Corporation

XRX

Xerox Holdings Corporation

HOLD

Current Price

$2.74

Market Cap

368.8M

Sector

Technology

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$5.48

Market Cap

361.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XRX
VNDA
Founded
1906
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
368.8M
361.4M
IPO Year
2019
2005

Fundamental Metrics

Financial Performance
Metric
XRX
VNDA
Price
$2.74
$5.48
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$2.50
$14.90
AVG Volume (30 Days)
3.5M
858.1K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
6.31%
N/A
EPS Growth
23.26
N/A
EPS
N/A
N/A
Revenue
$117,000,000.00
$216,105,000.00
Revenue This Year
$8.96
$21.35
Revenue Next Year
N/A
$37.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.72
52 Week Low
$1.19
$4.14
52 Week High
$6.80
$9.91

Technical Indicators

Market Signals
Indicator
XRX
VNDA
Relative Strength Index (RSI) 43.52 35.47
Support Level $2.40 $5.11
Resistance Level $2.89 $5.58
Average True Range (ATR) 0.19 0.23
MACD -0.03 -0.08
Stochastic Oscillator 19.20 11.99

Price Performance

Historical Comparison
XRX
VNDA

About XRX Xerox Holdings Corporation

Xerox Holdings Corp is a workplace technology company, building and integrating services-led, software-enabled, workplace solutions for enterprises large and small. It provide advance document technology, services, software, and integrated IT infrastructure solutions for a range of customers including small and mid-sized businesses, large enterprises, governments and graphic communications providers, and for partners who serve them. Xerox serves customers globally in North America, Europe, Latin America, Brazil, Asia Pacific (APAC), the Middle East, Africa, and India.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: